What does a 24-hour urine copper of 350 mean? For someone on long-term penicillamine or trientine, it sits inside the range the American Association for the Study of Liver Diseases (AASLD) calls stable, and for someone on zinc it is more than 3 times the top of the zinc range, which is worth a call to the doctor. Wilson disease is one of the few conditions where the same lab number can be good news or a warning depending on the medicine you take.
Why Wilson Disease Copper Tests Read Differently on Each Medicine
Chelators pull copper out of the body through the kidneys, so they push the copper in your urine up, while zinc blocks copper from being absorbed in the gut, so it brings urine copper down. The AASLD guidance summary says a low urine copper on zinc is itself a sign the pills are being taken (Alkhouri et al., 2023).
Four medicines are FDA approved for Wilson disease. Penicillamine (Cuprimine, Depen and generics) and trientine hydrochloride (Syprine and generics) are the older chelators; Cuvrior is a newer trientine salt for stable adults switching from penicillamine; Galzin is zinc acetate for maintenance after chelation. Our side-by-side comparison covers how each is taken, and this guide covers the numbers that come back from the lab.
Timing matters too. Right after a chelator is started, urine copper runs high as stored copper is flushed out, then settles (AASLD guidance summary, Alkhouri et al., 2023). A result that would worry a doctor in year 5 can be what they hope to see in week 2.
Wilson Disease 24-Hour Urine Copper Targets for Penicillamine, Trientine and Zinc
The stable 24-hour urine copper target is 200 to 500 mcg on penicillamine, 150 to 500 mcg on trientine and under 100 mcg on zinc, according to the AASLD guidance. The FDA labels give their own figures, and they do not all match the guidance, which is why the chart below puts both on one scale.
On a chelator, a stable 24-hour urine copper sits far higher than on zinc, and the labels for penicillamine and Syprine expect free copper under 10 mcg/dL in well-treated patients. Sources: the Cuprimine, Syprine, Cuvrior and Galzin FDA labels and the AASLD guidance summary; Cuvrior's free copper values were converted from micrograms per liter by dividing by 10.
Lined up together, the documents disagree in one place that matters for anyone on trientine. The Syprine label says a person is probably in the desired negative copper balance when a 24-hour urine holds 0.5 to 1.0 mg of copper, which is 500 to 1,000 mcg, while the AASLD guidance puts stable trientine treatment at 150 to 500 mcg. A result of 700 can therefore look on target against the label and high against the guidance, so ask which reference your care team uses.
Cuvrior adds a second wrinkle. In its trial, 26 adults who switched from penicillamine averaged 274 mcg of urine copper at week 36, against 511 mcg for the 27 who stayed on penicillamine, while free copper in the blood was similar between the groups (Cuvrior label, 2025). The label notes that urine copper falls when people move from penicillamine to a trientine product, so a lower number after that switch is something the label anticipates.
What Free Copper Means on a Wilson Disease Lab Report
Free copper, also called non-ceruloplasmin copper or NCC, is the copper in your blood that is not attached to ceruloplasmin, the protein that normally carries it, and it is the part that damages the liver and brain. The penicillamine and Syprine labels both say adequately treated patients usually have less than 10 mcg/dL.
Many labs do not print it, but you can estimate it from 2 numbers that are usually on the report. The Galzin label states that each milligram of ceruloplasmin carries 3 micrograms of copper, so free copper in mcg/dL is roughly total serum copper in mcg/dL minus 3 times ceruloplasmin in mg/dL. A total copper of 70 with a ceruloplasmin of 20 gives 70 minus 60, or about 10 mcg/dL.
The Copper Number New Wilson Disease Drugs Are Judged On
The AASLD guidance leans on 24-hour urine copper to follow treatment, yet none of the 4 Phase 3 Wilson disease drug trials started since 2018 and listed on ClinicalTrials.gov chose it as the main measure. We read the registered main goal of each one, and all 4 picked free copper in the blood.
The ALXN1840 Phase 3 trial (NCT03403205) measured free copper directly by mass spectrometry after removing ceruloplasmin. Cuvrior's trial (NCT03539952) and the new TRADITiONAL trial (NCT07465718) both use a speciation assay, and a pediatric ALXN1840 trial (NCT05047523) planned to measure free copper in plasma before it ended early. Of the 4, only Cuvrior's trial lists 24-hour urine copper among its registered outcomes.
Europe's newest guidance leans the same way. The 2025 EASL-ERN guideline recommends adding relative exchangeable copper, a direct test of loosely bound copper, at diagnosis when it is available, and lists exchangeable copper alongside urine copper among the measures for following treatment (Socha et al., 2025). On ClinicalTrials.gov, exchangeable copper appears among the outcomes of only 2 of 44 Wilson disease treatment studies we counted on October 13, 2026.
For families, the practical gap is that a drug's trial results may be reported in a free copper number your own lab cannot produce the same way. When you read results for ALXN1840, Cuvrior or a gene therapy, ask your hepatologist how those figures compare with the urine copper and calculated free copper on your own reports.
Signs of Too Much Wilson Disease Treatment Your Labs Can Show
Low blood counts, a rising ferritin and an unusually low urine copper, under 100 mcg in 24 hours on a chelator or under 20 mcg on zinc, may mean too much treatment, according to the AASLD guidance summary. Too much treatment leaves the body short of copper, which it needs for blood and nerves, and the guidance says it can be corrected by lowering the dose or briefly interrupting treatment, decisions your doctor makes.
The Cuvrior and Galzin labels both warn about copper deficiency. Galzin's label says that if signs of it appear, zinc is interrupted while zinc, 24-hour urine copper and free copper are measured, and restarting is considered based on later urine copper and free copper results. None of this means stopping on your own: Wilson disease medicine is lifelong, and missed or stopped doses let copper build up again.
How Often Wilson Disease Copper and Liver Tests Are Checked
Expect regular 24-hour urine copper tests plus liver tests, a clotting test (INR), blood counts, a urine test and serum copper and ceruloplasmin twice a year, as the AASLD guidance summary recommends for people on treatment. Each medicine adds its own schedule on top of that.
Penicillamine has the tightest one: its label calls for urine tests and blood counts twice a week in the first month, every 2 weeks for the next 5 months, then monthly. Cuvrior's label asks for free copper at the start, after 3 months and about every 6 months, with a 24-hour urine copper every 6 to 12 months. On Galzin, the label notes that 24-hour urine zinc can show whether the doses are being taken.
Collection itself can skew the result. The penicillamine, Syprine and Galzin labels all say the urine must go into copper-free glassware or containers, so ask the lab for the right jug rather than using one from home, and keep all 24 hours of urine in it as the lab's instructions describe.
New Wilson Disease Treatments and Trials to Ask About in 2026
ALXN1840 (bis-choline tetrathiomolybdate), a copper-binding medicine licensed to Monopar Therapeutics, is the nearest to an FDA filing. Monopar began a rolling application on July 22, 2026 and, as of October 13, 2026, had not announced that the submission was complete, so there is no FDA decision date yet. Our ALXN1840 page will update when one is set.
Gene-based approaches are moving too. Ultragenyx's UX701 gene therapy is in the Cyprus2+ trial (NCT04884815), which is no longer recruiting, and the company expects early dose-finding results in the fourth quarter of 2026. Prime Medicine reported dosing the first patient in its PM577a trial on October 5, 2026 (NCT07748403), for people 12 and older with at least 1 copy of the H1069Q variant.
Orphalan's Phase 3 TRADITiONAL trial, which started in September 2026, is recruiting people 8 and older to compare once-daily trientine tetrahydrochloride with penicillamine as a first treatment. Trial teams screen on copper results like the ones in this guide, so bring your last 2 or 3 reports. The Wilson disease trials page lists every open study, and Match Me checks your answers against their rules.
One email when Wilson Disease trials change or an FDA decision lands. No newsletter, no spam.
You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Wilson Disease. Turn any of these off from the link in every email.
Questions to Bring to Your Next Wilson Disease Appointment
Ask what your own urine copper and free copper targets are, and which reference they come from. Ask whether your last sample went into a copper-free container, whether your dose changed since the test before, and whether a falling number means your treatment is working or going too far. Keeping a single page with each result, the date, your medicine and your dose makes those conversations much shorter.
The Wilson Disease Association keeps a list of treatment centers and runs patient support programs, and our Wilson disease page can email you when a new trial opens or an FDA decision date is set.
What is a normal 24-hour urine copper for Wilson disease?
On long-term treatment, the AASLD guidance puts a stable 24-hour urine copper at 200 to 500 mcg on penicillamine, 150 to 500 mcg on trientine and under 100 mcg on zinc. Before treatment, the guidance says urine copper is usually above 100 mcg a day in people with symptoms, and a value above 40 mcg may point to Wilson disease in children or people without symptoms.
What is a good free copper level in Wilson disease?
The penicillamine and Syprine labels say well-treated patients usually have free copper under 10 mcg/dL. The Syprine label adds that the dose is raised only if free copper stays above 20 mcg/dL or the clinical response is not adequate.
Why did my urine copper go down after switching from penicillamine to Cuvrior?
Urine copper is expected to fall after a switch to a trientine product, according to the Cuvrior label. In its trial, people who switched averaged 274 mcg a day against 511 mcg for those who stayed on penicillamine, while free copper was similar.
Can zinc treatment for Wilson disease make urine copper too low?
Yes, the AASLD guidance treats a 24-hour urine copper under 20 mcg on zinc as a possible sign of too much treatment. The Galzin label says an adequate dose eventually brings urine copper to 125 mcg a day or less, and a steady rise suggests copper control is slipping.
Which copper test do Wilson disease clinical trials use?
Every Phase 3 Wilson disease drug trial started since 2018 and listed on ClinicalTrials.gov made free copper in the blood (NCC) its main measure, and 3 of the 4 named a specialized lab method. Most clinics still follow patients with 24-hour urine copper and free copper calculated from ceruloplasmin.
How do I collect a 24-hour urine for copper?
Use the copper-free container your lab provides and keep all of your urine for a full 24 hours, following the lab's start and stop instructions. The FDA labels for penicillamine, Syprine and Galzin all say the urine must be collected in copper-free glassware or containers.